S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
It's Called "the Singularity" (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
It's Called "the Singularity" (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
1907, 1929, 1998, 2007--and now 2023? (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
It's Called "the Singularity" (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
It's Called "the Singularity" (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
1907, 1929, 1998, 2007--and now 2023? (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
It's Called "the Singularity" (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
It's Called "the Singularity" (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
1907, 1929, 1998, 2007--and now 2023? (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Latest freight railroad layoffs and Wall Street pressure renew concerns about safety and service
It's Called "the Singularity" (Ad)
Dell, NetApp rise; Ginkgo Bioworks, New York Community Bancorp fall, Friday, 3/1/2024
How major US stock indexes fared Friday, 3/1/2024
It's Called "the Singularity" (Ad)
China pledges to increase opportunities for foreign companies as it seeks to boost its economy
Brazil's economy grows 2.9% in Lula's 1st year, beating expectations
1907, 1929, 1998, 2007--and now 2023? (Ad)
Question of whether Nebraska public money can go to private schools still set for November ballot
A US appeals court ruling could allow mine development on Oak Flat, land sacred to Apaches
LON:SCLP

Scancell (SCLP) Share Price, News & Analysis

GBX 10.50
0.00 (0.00%)
(As of 03/1/2024 ET)
Today's Range
10.25
10.95
50-Day Range
10.25
12
52-Week Range
7.59
21
Volume
250,257 shs
Average Volume
401,173 shs
Market Capitalization
£97.42 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SCLP stock logo

About Scancell Stock (LON:SCLP)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

SCLP Stock Price History

SCLP Stock News Headlines

This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Scancell Holdings Share Chat
Scancell Holdings plc (SCP.F)
Scancell fundraiser brings in £10.7m after it is 'upsized'
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
Scancell shares are on fire! Should I buy?
Scancell jumps 23% after trial data; analysts hail results
Scancell jump 23% after trial data; analysts hail results
Scancell appoints head of business development
Scancell Plc (LSE: SCLP)
See More Headlines
Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
1/31/2020
Today
3/02/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Net Income
£-9,530,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£5.27 million
Cash Flow
GBX 1.34 per share
Book Value
GBX (1) per share

Miscellaneous

Free Float
N/A
Market Cap
£97.42 million
Optionable
Not Optionable
Beta
0.35
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Prof. Lindy Gillian Durrant Ph.D. (Age 67)
    Founder, CEO, Chief Scientific Officer & Director
    Comp: $369.12k














SCLP Stock Analysis - Frequently Asked Questions

How have SCLP shares performed in 2024?

Scancell's stock was trading at GBX 10.50 at the beginning of 2024. Since then, SCLP shares have increased by 0.0% and is now trading at GBX 10.50.
View the best growth stocks for 2024 here
.

How were Scancell's earnings last quarter?

Scancell Holdings plc (LON:SCLP) posted its quarterly earnings results on Friday, January, 31st. The company reported ($0.56) earnings per share for the quarter.

What other stocks do shareholders of Scancell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO), Empyrean Energy (EME), Lloyds Banking Group (LYG), Aminex (AEX) and Sound Energy (SOU).

How do I buy shares of Scancell?

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SCLP) was last updated on 3/2/2024 by MarketBeat.com Staff